Arformoterol Tartrate Solution
Product Images NDC 42571-464

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 42571-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Arformoterol-crt.jpg (Arformoterol Crt)

The packaging label for Arformoterol Tartrate Inhalation Solution, 15 mcg per 2 mL, displays the product as a sterile solution for oral inhalation only. The package contains 30 unit-dose vials of 2 mL each. It includes storage instructions to keep refrigerated or store at room temperature for up to 6 weeks. The labeler is Micro Labs Limited, with manufacturing noted in India and distribution by Micro Labs USA, Inc.*

FDA Label Image

Arformoterol-figa.jpg (Arformoterol Figa)

A line graph showing the mean change from baseline FEV1 (L) over 12 hours postdose comparing placebo and 15 mcg Arformoterol Tartrate inhalation solution administered twice daily (BID). The placebo group shows minimal increase, while the Arformoterol group exhibits a rapid and sustained increase in FEV1, indicating improved lung function over the 12-hour period.*

FDA Label Image

Arformoterol-figb.jpg (Arformoterol Figb)

A line graph showing mean change from baseline FEV1 (L) over 12 hours postdose for Arformoterol Tartrate Inhalation Solution 15 mcg BID versus placebo. The graph plots time (hours postdose) on the x-axis and mean FEV1 change (L) on the y-axis, with Arformoterol showing an increase peaking early and gradually declining, while placebo remains near zero or slightly negative.*

FDA Label Image

Arformoterol-insta.jpg (Arformoterol Insta)

An instructional diagram showing a hand holding a respiratory inhalation device with a thumb pressing and twisting the base, indicating the motion needed to prepare or activate the device for use.*

FDA Label Image

Arformoterol-instb.jpg (Arformoterol Instb)

An instructional diagram showing a hand pressing down on a device labeled "RESERVOIR," indicating an action likely related to filling or activating the reservoir component of a respiratory inhalation device.*

FDA Label Image

Arformoterol-instc.jpg (Arformoterol Instc)

Two black and white instructional illustrations related to respiratory drug use. One shows a mouthpiece attached to a device for inhalation (labeled Figure 3). The other shows a face mask positioned over a patient's face for inhalation therapy (labeled Figure 4). Both images depict components used in administering inhaled medication.*

FDA Label Image

Arformoterol-instd.jpg (Arformoterol Instd)

An illustration showing a compressor device connected to tubing. The compressor is labeled "COMPRESSOR" with a knob and a rectangular display or window visible on its front panel. Tubing is attached to the lower part of the device, indicating a setup likely related to respiratory treatment.*

FDA Label Image

Arformoterol-inste.jpg (Arformoterol Inste)

An instructional illustration showing the correct use of a respiratory solution inhaler. The image depicts a person holding the inhaler close to their mouth with the mouthpiece positioned for inhalation, demonstrating proper administration technique for Arformoterol Tartrate solution.*

FDA Label Image

Arformoterol-pouch.jpg (Arformoterol Pouch)

Arformoterol Tartrate 15 mcg/2 mL Inhalation Solution sterile unit-dose vial label. It is for oral inhalation only and includes dosing and storage instructions. Labeler is Micro Labs Limited, with manufacturing in India and the United States. The vial contains 2 mL solution with potency expressed as arformoterol.*

FDA Label Image

Arformoterol-str.jpg (Arformoterol Str)

Chemical structure diagram showing molecular formulas of Arformoterol Tartrate. The image depicts two complex molecular structures representing the active ingredient and its tartrate salt form.*

FDA Label Image

Arformoterol-vial.jpg (Arformoterol Vial)

Label for Arformoterol Tartrate Inhalation Solution 15 mcg per 2 mL sterile vial, intended for oral inhalation only. The product is made in India and supplied in a 2 mL vial. The label includes the NDC 42571-464-75 and is manufactured by Micro Labs Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.